[quote]I think you're being called a troll because you're posting generalizations and other posters are doing you the courtesy of assuming that you know better, rather than being mentally dull.
Thank you. That's...very passive aggressive and distracting. Moving on.
[quote]The BMJ "article" you posted was an editorial by an editor who had concerns...it doesn't go into any—just offers educated concerns and speculation.
No. The author actually provided data and evidence (and linked the source) and unpacked said data. This one in particular stands out:
"And on preventing death from covid-19, there are too few data to draw conclusions—a total of three covid-19 related deaths (one on vaccine, two on placebo). There were 29 total deaths during blinded follow-up (15 in the vaccine arm; 14 in placebo).
The crucial question, however, is whether the waning efficacy seen in the primary endpoint data also applies to the vaccine’s efficacy against severe disease. Unfortunately, Pfizer’s new preprint does not report the results in a way that allows for evaluating this question."
I chose that article specifically because it is the best one that outlines literally all of the questions and concerns I have about the vaccine [italic]at this stage[/italic]. I am on the side that thinks more time is needed to gather enough data to accurately measure the vaccine's efficacy and if, indeed, the risk for ADE is almost non-existent (with coronaviruses, similar to dengue virus, this is quite common). We don't know yet how and when ADE may come about (if it hasn't already) because enough time hasn't passed. Again, even on the fast tracked timeline, it's approximately 2 years before any more robust data can be collected. It's essentially a waiting game. But, certain numbers are also concerning. These are numbers for the 50+ demographic from the UK up to 8/12/21:
UK POPULATION MID-2020 = 56,550,138 UK POPULATION 50+ MID 2020 = 24,153,564 (43% of overall population) FULLY VACCINATED 50+ = 19,823,127 (82% of overall 50+ UK population)
RECEIVED 1ST DOSE 50+ = 16,765,422 (69% of overall 50+ UK population; 85% of fully vaccinated 50+ population)
UNVACCINATED 50+ = ~7,388,142 (~31% of overall 50+ population)
DELTA CASES TOTAL: 386,735
DELTA CASES 50+ = 48,264 (13% OF ALL DELTA CASES AND 0.2% OF UK 50+ POPULATION)
DELTA CASES UNVACCINATED 50+ = 4,891 (10% OF 50+ CASES AND 0.07% OF UNVACCINATED 50+ POPULATION)
DELTA CASES 1ST DOSE 50+ = 6,303 (1.6% OF 50+ CASES AND 0.03% OF 1ST DOSE 50+ POPULATION)
DELTA CASES FULLY VACCINATED 50+ = 32,828 (68% OF 50+ CASES AND 0.17% OF FULLY VACCINATED 50+ POPULATION)
DEATHS WITHIN 28 DAYS OF POSITIVE TEST 50+ = 1,076 (2.2% OF ALL 50+ CASES)
DEATHS WITHIN 28 DAYS OF POSITIVE TEST UNVACCINATED 50+ = 318 (0.66% OF 50+ CASES AND 6.5% OF UNVACCINATED 50+ CASES, 30% OF ALL 50+ DEATHS, 0.004% of UNVACCINATED 50+ POPULATION)
DEATHS WITHIN 28 DAYS OF POSITIVE TEST 1ST DOSE 50+ = 93 (0.19% OF 50+ CASES AND 1.5% OF 1ST DOSE 50+ CASES, 8.6% OF ALL 50+ DEATHS, 0.005% OF 1ST 50+ UK POPULATION)
DEATHS WITHIN 28 DAYS OF POSITIVE TEST FULLY VACCINATED 50+ = 652 (1.4% OF 50+ CASES AND 2% OF FULLY VACCINATED 50+ CASES, 60% OF ALL 50+ DEATHS, 0.003% OF FULLY VACCINATED 50+ UK POPULATION)
From here it appears that more unvaccinated 50+ become infected (not surprisingly) compared to fully vaccinated 50+. However, they are dying at a lesser rate from the illness than the fully vaccinated group.